ACADIA Pharmaceuticals Inc (ACAD)
17.24
+0.20
(+1.14%)
USD |
NASDAQ |
May 06, 12:24
ACADIA Pharmaceuticals 1 Year Total Returns (Daily): -19.58% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | -19.58% |
| May 02, 2024 | -20.11% |
| May 01, 2024 | -21.61% |
| April 30, 2024 | -21.66% |
| April 29, 2024 | -19.83% |
| April 26, 2024 | -17.73% |
| April 25, 2024 | -18.90% |
| April 24, 2024 | -17.63% |
| April 23, 2024 | -16.68% |
| April 22, 2024 | -15.43% |
| April 19, 2024 | -15.98% |
| April 18, 2024 | -13.44% |
| April 17, 2024 | -11.25% |
| April 16, 2024 | -5.06% |
| April 15, 2024 | -6.11% |
| April 12, 2024 | -6.54% |
| April 11, 2024 | -3.76% |
| April 10, 2024 | -0.39% |
| April 09, 2024 | -1.09% |
| April 08, 2024 | -3.00% |
| April 05, 2024 | -1.48% |
| April 04, 2024 | -2.33% |
| April 03, 2024 | -2.69% |
| April 02, 2024 | -3.77% |
| April 01, 2024 | -2.98% |
| Date | Value |
|---|---|
| March 28, 2024 | 0.33% |
| March 27, 2024 | -2.15% |
| March 26, 2024 | -2.47% |
| March 25, 2024 | -2.19% |
| March 22, 2024 | -2.97% |
| March 21, 2024 | -5.35% |
| March 20, 2024 | -5.57% |
| March 19, 2024 | -5.56% |
| March 18, 2024 | -5.45% |
| March 15, 2024 | -6.90% |
| March 14, 2024 | -8.10% |
| March 13, 2024 | 0.77% |
| March 12, 2024 | -1.91% |
| March 11, 2024 | 18.46% |
| March 08, 2024 | 12.86% |
| March 07, 2024 | 15.52% |
| March 06, 2024 | 12.46% |
| March 05, 2024 | 17.06% |
| March 04, 2024 | 16.76% |
| March 01, 2024 | 14.77% |
| February 29, 2024 | 12.32% |
| February 28, 2024 | 14.77% |
| February 27, 2024 | 35.88% |
| February 26, 2024 | 36.89% |
| February 23, 2024 | 29.74% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-66.72%
Minimum
Dec 01 2021
217.4%
Maximum
Dec 24 2019
19.37%
Average
12.85%
Median
Feb 19 2021
1 Year Total Returns (Daily) Benchmarks
| Amylyx Pharmaceuticals Inc | -92.77% |
| Regulus Therapeutics Inc | 103.8% |
| Minerva Neurosciences Inc | -48.70% |
| Viking Therapeutics Inc | 258.8% |
| CytomX Therapeutics Inc | 168.5% |